HEADER LYASE 07-AUG-01 1GK3 TITLE HISTIDINE AMMONIA-LYASE (HAL) MUTANT D145A FROM PSEUDOMONAS PUTIDA COMPND MOL_ID: 1; COMPND 2 MOLECULE: HISTIDINE AMMONIA-LYASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: HISTIDASE, HAL; COMPND 5 EC: 4.3.1.3; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 OTHER_DETAILS: THIS MUTANT DOES NOT CONTAIN A 4-METHYLIDENE- COMPND 9 IMIDAZOLE-5-ONE GROUP. SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PSEUDOMONAS PUTIDA; SOURCE 3 ORGANISM_TAXID: 303; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PT7-7H KEYWDS LYASE, AMMONIA-LYASE, HISTIDINE DEGRADATION EXPDTA X-RAY DIFFRACTION AUTHOR M.BAEDEKER,G.E.SCHULZ REVDAT 4 20-JUN-18 1GK3 1 TITLE JRNL REMARK REVDAT 3 07-SEP-11 1GK3 1 COMPND SOURCE JRNL REMARK REVDAT 3 2 1 DBREF HETSYN FORMUL HETATM REVDAT 3 3 1 MASTER REVDAT 2 24-FEB-09 1GK3 1 VERSN REVDAT 1 21-FEB-02 1GK3 0 JRNL AUTH M.BAEDEKER,G.E.SCHULZ JRNL TITL AUTOCATALYTIC PEPTIDE CYCLIZATION DURING CHAIN FOLDING OF JRNL TITL 2 HISTIDINE AMMONIA-LYASE. JRNL REF STRUCTURE V. 10 61 2002 JRNL REFN ISSN 0969-2126 JRNL PMID 11796111 JRNL DOI 10.1016/S0969-2126(01)00692-X REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH T.F.SCHWEDE,J.RETEY,G.E.SCHULZ REMARK 1 TITL CRYSTAL STRUCTURE OF HISTIDINE AMMONIA-LYASE REVEALING A REMARK 1 TITL 2 NOVEL POLYPEPTIDE MODIFICATION AS THE CATALYTIC ELECTROPHILE REMARK 1 REF BIOCHEMISTRY V. 38 5355 1999 REMARK 1 REFN ISSN 0006-2960 REMARK 1 PMID 10220322 REMARK 1 DOI 10.1021/BI982929Q REMARK 1 REFERENCE 2 REMARK 1 AUTH T.F.SCHWEDE,M.BAEDEKER,M.LANGER,J.RETEY,G.E.SCHULZ REMARK 1 TITL HOMOGENIZATION AND CRYSTALLIZATION OF HISTIDINE REMARK 1 TITL 2 AMMONIA-LYASE BY EXCHANGE OF A SURFACE CYSTEINE RESIDUE REMARK 1 REF PROTEIN ENG. V. 12 151 1999 REMARK 1 REFN ISSN 0269-2139 REMARK 1 PMID 10195286 REMARK 1 DOI 10.1093/PROTEIN/12.2.151 REMARK 2 REMARK 2 RESOLUTION. 2.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELX REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 21.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 91.0 REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.221 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.280 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 26022 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : NULL REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE (F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3761 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 11 REMARK 3 SOLVENT ATOMS : 184 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : NULL REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : NULL REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : NULL REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : NULL REMARK 3 NUMBER OF RESTRAINTS : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 ANGLE DISTANCES (A) : 0.016 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : NULL REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : NULL REMARK 3 ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : NULL REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : NULL REMARK 3 SIMILAR ADP COMPONENTS (A**2) : NULL REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : NULL REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: RESIDUES 272-275 AND 363-374 NOT REMARK 3 VISIBLE IN ELECTRON DENSITY REMARK 4 REMARK 4 1GK3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 07-AUG-01. REMARK 100 THE DEPOSITION ID IS D_1290008405. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.10 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUB200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26022 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.250 REMARK 200 RESOLUTION RANGE LOW (A) : 21.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.0 REMARK 200 DATA REDUNDANCY : 2.300 REMARK 200 R MERGE (I) : 0.12600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 2.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.06 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.80 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CRYSTALLIZED FROM 2.0 M (NH4)2SO4, 1 % REMARK 280 GLYCEROL, 2 % PEG 400, 0.1 M HEPES AT PH 8.1. 20 % (V/V) REMARK 280 GLYCEROL WERE USED AS CRYOPROTECTANT, PH 8.10 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 39.40750 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 58.55250 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 65.03600 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 39.40750 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 58.55250 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 65.03600 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 39.40750 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 58.55250 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 65.03600 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 39.40750 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 58.55250 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 65.03600 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 27360 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 55480 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -213.3 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 350 BIOMT1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 3 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 350 BIOMT1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 4 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A2059 LIES ON A SPECIAL POSITION. REMARK 375 HOH A2127 LIES ON A SPECIAL POSITION. REMARK 375 HOH A2144 LIES ON A SPECIAL POSITION. REMARK 375 HOH A2145 LIES ON A SPECIAL POSITION. REMARK 400 REMARK 400 COMPOUND REMARK 400 CHAIN A ENGINEERED MUTATION CYS273ALA, ASP145ALA REMARK 400 MUTANT D145A IS UNABLE TO FORM THE CATALYTICALLY ESSENTIAL REMARK 400 ELECTROPHILE MIO REMARK 475 REMARK 475 ZERO OCCUPANCY RESIDUES REMARK 475 THE FOLLOWING RESIDUES WERE MODELED WITH ZERO OCCUPANCY. REMARK 475 THE LOCATION AND PROPERTIES OF THESE RESIDUES MAY NOT REMARK 475 BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 475 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE) REMARK 475 M RES C SSEQI REMARK 475 ASN A 272 REMARK 475 ALA A 273 REMARK 475 ASP A 274 REMARK 475 LYS A 275 REMARK 475 HIS A 363 REMARK 475 MET A 364 REMARK 475 SER A 365 REMARK 475 GLN A 366 REMARK 475 LEU A 367 REMARK 475 PRO A 368 REMARK 475 PRO A 369 REMARK 475 PHE A 370 REMARK 475 LEU A 371 REMARK 475 VAL A 372 REMARK 475 GLU A 373 REMARK 475 ASN A 374 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASP A 361 CD2 HIS A 363 1.80 REMARK 500 OD1 ASP A 361 NE2 HIS A 363 1.83 REMARK 500 CB ALA A 273 O HOH A 2106 1.93 REMARK 500 OE1 GLU A 43 O HOH A 2029 2.17 REMARK 500 O HOH A 2006 O HOH A 2013 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OG SER A 393 OD2 ASP A 405 4555 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 ALA A 147 N ALA A 147 CA 0.191 REMARK 500 ALA A 384 N ALA A 384 CA 0.135 REMARK 500 VAL A 386 N VAL A 386 CA 0.156 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ALA A 147 C - N - CA ANGL. DEV. = -19.3 DEGREES REMARK 500 ALA A 147 N - CA - CB ANGL. DEV. = -9.5 DEGREES REMARK 500 ALA A 384 N - CA - C ANGL. DEV. = -23.6 DEGREES REMARK 500 ARG A 465 NE - CZ - NH1 ANGL. DEV. = 3.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 56 25.24 -148.23 REMARK 500 ALA A 63 -7.59 -53.18 REMARK 500 ALA A 68 125.26 -38.60 REMARK 500 GLN A 76 -71.73 -34.09 REMARK 500 ALA A 142 122.59 -178.14 REMARK 500 SER A 143 22.31 109.56 REMARK 500 ALA A 145 17.46 -55.04 REMARK 500 LEU A 146 -96.82 1.55 REMARK 500 LYS A 188 -23.57 71.71 REMARK 500 LYS A 271 -77.59 -8.06 REMARK 500 ASP A 274 -83.23 -129.73 REMARK 500 LYS A 275 -147.45 26.66 REMARK 500 VAL A 276 140.83 -37.48 REMARK 500 PHE A 317 78.07 -110.65 REMARK 500 LYS A 362 46.58 -71.33 REMARK 500 HIS A 363 -96.38 171.77 REMARK 500 MET A 364 -5.67 1.01 REMARK 500 SER A 365 -39.59 -136.08 REMARK 500 GLN A 366 8.78 93.08 REMARK 500 LEU A 367 -160.14 -111.22 REMARK 500 PRO A 369 0.31 -52.77 REMARK 500 PHE A 370 -7.80 -164.16 REMARK 500 LEU A 371 -45.92 103.62 REMARK 500 VAL A 372 -83.27 -59.02 REMARK 500 GLU A 373 52.13 162.50 REMARK 500 ASN A 374 124.97 121.19 REMARK 500 ASN A 378 -119.59 -117.09 REMARK 500 SER A 379 24.41 160.74 REMARK 500 SER A 410 57.03 26.27 REMARK 500 ALA A 411 46.39 84.48 REMARK 500 ASN A 412 24.63 44.73 REMARK 500 THR A 457 -158.02 -102.52 REMARK 500 TYR A 475 43.09 -104.94 REMARK 500 ASP A 476 -8.69 -40.55 REMARK 500 ARG A 477 166.08 169.40 REMARK 500 ASP A 478 111.53 -12.07 REMARK 500 ARG A 479 149.67 166.20 REMARK 500 PHE A 480 109.52 -47.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1510 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1511 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1EB4 RELATED DB: PDB REMARK 900 HISTIDINE AMMONIA-LYASE (HAL) MUTANT F329A FROM PSEUDOMONAS PUTIDA REMARK 900 RELATED ID: 1GKM RELATED DB: PDB REMARK 900 HISTIDINE AMMONIA-LYASE (HAL) FROM PSEUDOMONAS PUTIDA INHIBITED REMARK 900 WITH L-CYSTEINE REMARK 900 RELATED ID: 1GK2 RELATED DB: PDB REMARK 900 HISTIDINE AMMONIA-LYASE (HAL) MUTANT F329G FROM PSEUDOMONAS PUTIDA REMARK 900 RELATED ID: 1GKJ RELATED DB: PDB REMARK 900 HISTIDINE AMMONIA-LYASE (HAL) MUTANT Y280F FROM PSEUDOMONAS PUTIDA REMARK 900 RELATED ID: 1B8F RELATED DB: PDB REMARK 900 HISTIDINE AMMONIA-LYASE (HAL) FROM PSEUDOMONAS PUTIDA DBREF 1GK3 A 1 509 UNP P21310 HUTH_PSEPU 2 510 SEQADV 1GK3 ALA A 145 UNP P21310 ASP 145 ENGINEERED MUTATION SEQADV 1GK3 ALA A 273 UNP P21310 CYS 273 ENGINEERED MUTATION SEQRES 1 A 509 THR GLU LEU THR LEU LYS PRO GLY THR LEU THR LEU ALA SEQRES 2 A 509 GLN LEU ARG ALA ILE HIS ALA ALA PRO VAL ARG LEU GLN SEQRES 3 A 509 LEU ASP ALA SER ALA ALA PRO ALA ILE ASP ALA SER VAL SEQRES 4 A 509 ALA CYS VAL GLU GLN ILE ILE ALA GLU ASP ARG THR ALA SEQRES 5 A 509 TYR GLY ILE ASN THR GLY PHE GLY LEU LEU ALA SER THR SEQRES 6 A 509 ARG ILE ALA SER HIS ASP LEU GLU ASN LEU GLN ARG SER SEQRES 7 A 509 LEU VAL LEU SER HIS ALA ALA GLY ILE GLY ALA PRO LEU SEQRES 8 A 509 ASP ASP ASP LEU VAL ARG LEU ILE MET VAL LEU LYS ILE SEQRES 9 A 509 ASN SER LEU SER ARG GLY PHE SER GLY ILE ARG ARG LYS SEQRES 10 A 509 VAL ILE ASP ALA LEU ILE ALA LEU VAL ASN ALA GLU VAL SEQRES 11 A 509 TYR PRO HIS ILE PRO LEU LYS GLY SER VAL GLY ALA SER SEQRES 12 A 509 GLY ALA LEU ALA PRO LEU ALA HIS MET SER LEU VAL LEU SEQRES 13 A 509 LEU GLY GLU GLY LYS ALA ARG TYR LYS GLY GLN TRP LEU SEQRES 14 A 509 SER ALA THR GLU ALA LEU ALA VAL ALA GLY LEU GLU PRO SEQRES 15 A 509 LEU THR LEU ALA ALA LYS GLU GLY LEU ALA LEU LEU ASN SEQRES 16 A 509 GLY THR GLN ALA SER THR ALA TYR ALA LEU ARG GLY LEU SEQRES 17 A 509 PHE TYR ALA GLU ASP LEU TYR ALA ALA ALA ILE ALA CYS SEQRES 18 A 509 GLY GLY LEU SER VAL GLU ALA VAL LEU GLY SER ARG SER SEQRES 19 A 509 PRO PHE ASP ALA ARG ILE HIS GLU ALA ARG GLY GLN ARG SEQRES 20 A 509 GLY GLN ILE ASP THR ALA ALA CYS PHE ARG ASP LEU LEU SEQRES 21 A 509 GLY ASP SER SER GLU VAL SER LEU SER HIS LYS ASN ALA SEQRES 22 A 509 ASP LYS VAL GLN ASP PRO TYR SER LEU ARG CYS GLN PRO SEQRES 23 A 509 GLN VAL MET GLY ALA CYS LEU THR GLN LEU ARG GLN ALA SEQRES 24 A 509 ALA GLU VAL LEU GLY ILE GLU ALA ASN ALA VAL SER ASP SEQRES 25 A 509 ASN PRO LEU VAL PHE ALA ALA GLU GLY ASP VAL ILE SER SEQRES 26 A 509 GLY GLY ASN PHE HIS ALA GLU PRO VAL ALA MET ALA ALA SEQRES 27 A 509 ASP ASN LEU ALA LEU ALA ILE ALA GLU ILE GLY SER LEU SEQRES 28 A 509 SER GLU ARG ARG ILE SER LEU MET MET ASP LYS HIS MET SEQRES 29 A 509 SER GLN LEU PRO PRO PHE LEU VAL GLU ASN GLY GLY VAL SEQRES 30 A 509 ASN SER GLY PHE MET ILE ALA GLN VAL THR ALA ALA ALA SEQRES 31 A 509 LEU ALA SER GLU ASN LYS ALA LEU SER HIS PRO HIS SER SEQRES 32 A 509 VAL ASP SER LEU PRO THR SER ALA ASN GLN GLU ASP HIS SEQRES 33 A 509 VAL SER MET ALA PRO ALA ALA GLY LYS ARG LEU TRP GLU SEQRES 34 A 509 MET ALA GLU ASN THR ARG GLY VAL LEU ALA ILE GLU TRP SEQRES 35 A 509 LEU GLY ALA CYS GLN GLY LEU ASP LEU ARG LYS GLY LEU SEQRES 36 A 509 LYS THR SER ALA LYS LEU GLU LYS ALA ARG GLN ALA LEU SEQRES 37 A 509 ARG SER GLU VAL ALA HIS TYR ASP ARG ASP ARG PHE PHE SEQRES 38 A 509 ALA PRO ASP ILE GLU LYS ALA VAL GLU LEU LEU ALA LYS SEQRES 39 A 509 GLY SER LEU THR GLY LEU LEU PRO ALA GLY VAL LEU PRO SEQRES 40 A 509 SER LEU HET SO4 A1510 5 HET GOL A1511 6 HETNAM SO4 SULFATE ION HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 SO4 O4 S 2- FORMUL 3 GOL C3 H8 O3 FORMUL 4 HOH *184(H2 O) HELIX 1 1 THR A 11 ALA A 21 1 11 HELIX 2 2 ALA A 31 GLU A 48 1 18 HELIX 3 3 PHE A 59 ALA A 63 5 5 HELIX 4 4 ALA A 68 HIS A 70 5 3 HELIX 5 5 ASP A 71 ALA A 84 1 14 HELIX 6 6 ASP A 92 SER A 108 1 17 HELIX 7 7 ARG A 115 ALA A 128 1 14 HELIX 8 8 ALA A 145 LEU A 157 1 13 HELIX 9 9 ALA A 171 ALA A 178 1 8 HELIX 10 10 LYS A 188 ASN A 195 1 8 HELIX 11 11 THR A 197 VAL A 229 1 33 HELIX 12 12 ARG A 233 PHE A 236 5 4 HELIX 13 13 ASP A 237 GLY A 245 1 9 HELIX 14 14 GLN A 246 GLY A 261 1 16 HELIX 15 15 SER A 264 SER A 269 1 6 HELIX 16 16 PRO A 279 CYS A 284 1 6 HELIX 17 17 CYS A 284 ALA A 307 1 24 HELIX 18 18 ALA A 331 ASP A 361 1 31 HELIX 19 19 PHE A 381 SER A 399 1 19 HELIX 20 20 MET A 419 ARG A 426 1 8 HELIX 21 21 ARG A 426 ARG A 452 1 27 HELIX 22 22 SER A 458 SER A 470 1 13 HELIX 23 23 PHE A 481 LYS A 494 1 14 HELIX 24 24 LEU A 497 LEU A 501 5 5 SHEET 1 AA 2 GLU A 2 LEU A 5 0 SHEET 2 AA 2 ARG A 24 LEU A 27 1 O ARG A 24 N LEU A 3 SHEET 1 AB 2 ILE A 87 PRO A 90 0 SHEET 2 AB 2 PRO A 135 LYS A 137 -1 N LEU A 136 O ALA A 89 SHEET 1 AC 3 VAL A 130 PRO A 132 0 SHEET 2 AC 3 LYS A 161 TYR A 164 -1 O ARG A 163 N TYR A 131 SHEET 3 AC 3 GLN A 167 SER A 170 -1 O GLN A 167 N TYR A 164 SHEET 1 AD 2 LEU A 315 VAL A 316 0 SHEET 2 AD 2 VAL A 323 ILE A 324 -1 O ILE A 324 N LEU A 315 CISPEP 1 ASN A 313 PRO A 314 0 -5.47 SITE 1 AC1 4 TYR A 53 LEU A 191 ASN A 195 ASN A 313 SITE 1 AC2 10 GLY A 54 ILE A 55 ASN A 56 THR A 57 SITE 2 AC2 10 PHE A 59 LEU A 79 ALA A 187 LYS A 188 SITE 3 AC2 10 LEU A 191 HOH A2039 CRYST1 78.815 117.105 130.072 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012688 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008539 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007688 0.00000